Galiximab

Galiximab
Monoclonal antibody
Type Whole antibody
Source Chimeric (primate/human)
Target CD80
Clinical data
ATC code none
Identifiers
CAS Number 357613-77-5 N
ChemSpider none
UNII S9OX9692ZB YesY
KEGG D04295 YesY
 NYesY (what is this?)  (verify)

Galiximab is a monoclonal antibody designed for the treatment of B-cell lymphoma. As of September 2009, it is undergoing Phase III clinical trials.[1] The drug is a chimeric antibody from Macaca irus and Homo sapiens.[2]

References


This article is issued from Wikipedia - version of the 9/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.